Literature DB >> 30856654

Graphical Depiction of Longitudinal Study Designs in Health Care Databases.

Sebastian Schneeweiss1, Jeremy A Rassen2, Jeffrey S Brown3, Kenneth J Rothman4, Laura Happe5, Peter Arlett6, Gerald Dal Pan7, Wim Goettsch8, William Murk2, Shirley V Wang1.   

Abstract

Pharmacoepidemiologic and pharmacoeconomic analysis of health care databases has become a vital source of evidence to support health care decision making and efficient management of health care organizations. However, decision makers often consider studies done in nonrandomized health care databases more difficult to review than randomized trials because many design choices need to be considered. This is perceived as an important barrier to decision making about the effectiveness and safety of medical products. Design flaws in longitudinal database studies are avoidable but can be unintentionally obscured in the convoluted prose of methods sections, which often lack specificity. We propose a simple framework of graphical representation that visualizes study design implementations in a comprehensive, unambiguous, and intuitive way; contains a level of detail that enables reproduction of key study design variables; and uses standardized structure and terminology to simplify review and communication to a broad audience of decision makers. Visualization of design details will make database studies more reproducible, quicker to review, and easier to communicate to a broad audience of decision makers.

Mesh:

Year:  2019        PMID: 30856654     DOI: 10.7326/M18-3079

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  39 in total

1.  Transparent Reporting on Research Using Unstructured Electronic Health Record Data to Generate 'Real World' Evidence of Comparative Effectiveness and Safety.

Authors:  Shirley V Wang; Olga V Patterson; Joshua J Gagne; Jeffrey S Brown; Robert Ball; Pall Jonsson; Adam Wright; Li Zhou; Wim Goettsch; Andrew Bate
Journal:  Drug Saf       Date:  2019-11       Impact factor: 5.606

Review 2.  Transparency in real-world evidence (RWE) studies to build confidence for decision-making: Reporting RWE research in diabetes.

Authors:  Elisabetta Patorno; Sebastian Schneeweiss; Shirley V Wang
Journal:  Diabetes Obes Metab       Date:  2020-04       Impact factor: 6.577

3.  Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs: An Observational Study of US Women (Ages 18-64 Years).

Authors:  Tahir Rahman; John M Sahrmann; Margaret A Olsen; Katelin B Nickel; J Phillip Miller; Cynthia Ma; Richard A Grucza
Journal:  J Clin Psychopharmacol       Date:  2022 Jan-Feb 01       Impact factor: 3.153

4.  Association of Tramadol vs Codeine Prescription Dispensation With Mortality and Other Adverse Clinical Outcomes.

Authors:  Junqing Xie; Victoria Y Strauss; Daniel Martinez-Laguna; Cristina Carbonell-Abella; Adolfo Diez-Perez; Xavier Nogues; Gary S Collins; Sara Khalid; Antonella Delmestri; Aleksandra Turkiewicz; Martin Englund; Mina Tadrous; Carlen Reyes; Daniel Prieto-Alhambra
Journal:  JAMA       Date:  2021-10-19       Impact factor: 56.272

5.  Assessing and Interpreting Real-World Evidence Studies: Introductory Points for New Reviewers.

Authors:  Shirley V Wang; Sebastian Schneeweiss
Journal:  Clin Pharmacol Ther       Date:  2021-09-01       Impact factor: 6.875

6.  Long-term persistence and adherence with non-vitamin K oral anticoagulants in patients with atrial fibrillation and their associations with stroke risk.

Authors:  Joris J Komen; Eibert R Heerdink; Olaf H Klungel; Aukje K Mantel-Teeuwisse; Tomas Forslund; Björn Wettermark; Paul Hjemdahl
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2021-04-09

7.  Prescription medications for sleep disturbances among midlife women during 2 years of follow-up: a SWAN retrospective cohort study.

Authors:  Daniel H Solomon; Kristine Ruppert; Laurel A Habel; Joel S Finkelstein; Pam Lian; Hadine Joffe; Howard M Kravitz
Journal:  BMJ Open       Date:  2021-05-11       Impact factor: 2.692

8.  The Prognostic Significance of Body Mass Index and Metabolic Parameter Variabilities in Predialysis CKD: A Nationwide Observational Cohort Study.

Authors:  Sehoon Park; Semin Cho; Soojin Lee; Yaerim Kim; Sanghyun Park; Yong Chul Kim; Seung Seok Han; Hajeong Lee; Jung Pyo Lee; Kwon Wook Joo; Chun Soo Lim; Yon Su Kim; Kyungdo Han; Dong Ki Kim
Journal:  J Am Soc Nephrol       Date:  2021-08-12       Impact factor: 14.978

9.  Baseline Factors Associated with Mortality in Patients Who Engaged in Buprenorphine Treatment for Opioid Use Disorder: a Cohort Study.

Authors:  Danielle R Fine; Liyang Yu; Virginia A Triant; Travis P Baggett; Joshua P Metlay
Journal:  J Gen Intern Med       Date:  2020-03-23       Impact factor: 5.128

10.  Prescribing Patterns of Hydroxychloroquine and Glucocorticoids Among Lupus Patients After New-Onset End-Stage Renal Disease.

Authors:  Anna Broder; Wenzhu B Mowrey; Ana Valle; Mimi Kim; Candace H Feldman; Kazuki Yoshida; Karen H Costenbader
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-06-13       Impact factor: 5.178

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.